SERB Pharmaceuticals Overview

  • Year Founded
  • 1951

Year Founded

  • Status
  • Private

  • Employees
  • 500

Employees

  • Latest Deal Type
  • Debt Refin.

  • Financing Rounds
  • 7

  • Investments
  • 10

SERB Pharmaceuticals General Information

Description

Manufacturer of a specialty pharmaceutical group intended to focus on prescription medicines that address rare and life-threatening diseases. The company offers niche-branded prescription drugs for use in areas of medicine including critical and emergency care, neurology, diagnostics, and endocrinology.

Contact Information

Website
www.serb.com
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Corporate Office
  • 8 rue Beaumont
  • Luxembourg, 1219
  • Luxembourg
Primary Industry
Pharmaceuticals
Vertical(s)
Manufacturing, Life Sciences
Corporate Office
  • 8 rue Beaumont
  • Luxembourg, 1219
  • Luxembourg

SERB Pharmaceuticals Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

SERB Pharmaceuticals Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore SERB Pharmaceuticals‘s full profile, request access.

Request a free trial

SERB Pharmaceuticals Patents

  • 20

    Total Documents Applications and Grants

  • Total Patents Families

  • 13

    Granted

  • 1

    Pending

  • Expiring in next 12 mo

SERB Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11845977-B2 Methods of administering 3,4-diaminopridine Active 30-Jun-2011
US-11873525-B2 Methods of administering 3,4-diaminopridine Active 30-Jun-2011
US-20230295685-A1 Methods of administering 3,4-diaminopridine Active 30-Jun-2011
US-20230313265-A1 Methods of administering 3,4-diaminopridine Active 30-Jun-2011
US-10793893-B2 Methods of administering 3,4-diaminopyridine Active 30-Jun-2011 G01N33/564
To view SERB Pharmaceuticals’s complete patent history, request access »

SERB Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

SERB Pharmaceuticals Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore SERB Pharmaceuticals‘s full profile, request access.

Request a free trial

SERB Pharmaceuticals Investments (10)

SERB Pharmaceuticals’s most recent deal was a Buyout/LBO with Hansa Biopharma (Exclusive Rights to Sell Idefirix in Europe, Middle East And North Africa) for . The deal was made on 01-Jul-2026.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Hansa Biopharma (Exclusive Rights to Sell Idefirix in Europe, Middle East And North Africa) 01-Jul-2026 Buyout/LBO Buildings and Property
Y-mAbs Therapeutics 16-Sep-2025 Buyout/LBO Drug Discovery
CiVi Biopharma (Aurlumyn) 21-Oct-2024 Buyout/LBO Pharmaceuticals
Emergent Biosolutions (RSDL Kit Unit) 31-Jul-2024 Buyout/LBO Pharmaceuticals
Wellstat Therapeutics Corporation (Vistogard and Xuriden) 13-Jul-2023 Buyout/LBO Buildings and Property
You’re viewing 5 of 10 investments. Get the full list »

SERB Pharmaceuticals Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Veriton Pharma Weybridge, United Kingdom 1997

SERB Pharmaceuticals FAQs

  • When was SERB Pharmaceuticals founded?

    SERB Pharmaceuticals was founded in 1951.

  • Where is SERB Pharmaceuticals headquartered?

    SERB Pharmaceuticals is headquartered in Luxembourg, Luxembourg.

  • What is the size of SERB Pharmaceuticals?

    SERB Pharmaceuticals has 500 total employees.

  • What industry is SERB Pharmaceuticals in?

    SERB Pharmaceuticals’s primary industry is Pharmaceuticals.

  • Is SERB Pharmaceuticals a private or public company?

    SERB Pharmaceuticals is a Private company.

  • What is SERB Pharmaceuticals’s current revenue?

    The current revenue for SERB Pharmaceuticals is .

  • How much funding has SERB Pharmaceuticals raised over time?

    SERB Pharmaceuticals has raised $2.62B.

  • Who are SERB Pharmaceuticals’s investors?

    ESAS Holding, Merieux Equity Partners (Lyon), Partners Group, and Liberty Equity Management have invested in SERB Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process